486
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

ORCID Icon, , , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , , , , , , , , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 93-104 | Published online: 11 Aug 2021

References

  • Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601.
  • Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi:10.1016/S2213-2600(21)00031-X
  • National institute for health and care excellence: clinical guidelines. In: COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence (UK);2020.
  • Perego E, Callard F, Stras L, Melville-Jóhannesson B, Pope R, Alwan N. Why the patient-made term ‘long covid’ is needed [version 1; peer review: 1 approved with reservations, 1 not approved]. Wellcome Open Res. 2020;5(224).
  • Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026
  • Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. MedRxiv. 2020.
  • Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;192:113.
  • Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. doi:10.1371/journal.pone.0240784
  • Carfì A, Bernabei R, Landi F. Gemelli against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
  • Ganesh R, Ghosh AK, Nyman MA, et al. PROMIS scales for assessment of persistent post-COVID Symptoms: a cross sectional study. J Prim Care Community Health. 2021;12:21501327211030413. doi:10.1177/21501327211030413
  • Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network -United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–998. doi:10.15585/mmwr.mm6930e1
  • Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013–1022. doi:10.1002/jmv.26368
  • Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945. doi:10.3390/jcm10132945.
  • The prevalence of long COVID symptoms and COVID-19 complications [Website]. Office for national statistics. Available from: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications. Accessed February 2, 2021.
  • Jacobson KB, Rao M, Bonilla H, et al. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021. doi:10.1093/cid/ciab103
  • Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi:10.1038/s41591-021-01292-y
  • Böhning D, Rocchetti I, Maruotti A, Holling H. Estimating the undetected infections in the Covid-19 outbreak by harnessing capture–recapture methods. Int J Infect Dis. 2020;97:197–201. doi:10.1016/j.ijid.2020.06.009
  • Rocchetti I, Böhning D, Holling H, Maruotti A. Estimating the size of undetected cases of the COVID-19 outbreak in Europe: an upper bound estimator. J Epidemiol Methods. 2020;9:s1.
  • Arnold D, Hamilton F, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. Thorax. 2021;76(4):399. doi:10.1136/thoraxjnl-2020-216086
  • Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27(1):154–159. doi:10.1007/s13365-021-00949-1
  • Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2020;174:576.
  • Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England). 2021;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8
  • Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive and mental health impacts of COVID-19 following hospitalisation – a multi-centre prospective cohort study. MedRxiv. 2021.
  • Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020. doi:10.1183/23120541.00542-2020
  • National data opt-out [website]. NHS digital; 2021. Available from: https://digital.nhs.uk/services/national-data-opt-out/compliance-with-the-national-data-opt-out/check-for-national-data-opt-outs-service. Accessed July 16, 2021.
  • Peckham H, de Gruijter NM, Raine C, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi:10.1038/s41467-020-19741-6
  • Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000;16(6):511–518. doi:10.1023/A:1007629920752
  • Hewitt J, Carter B, Vilches-Moraga A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444–e451. doi:10.1016/S2468-2667(20)30146-8
  • COVID-19 rapid guideline: critical care in adults. National institute for clinical excellence; 2021. Available from: https://www.nice.org.uk/guidance/ng159/resources/covid19-rapid-guideline-critical-care-in-adults-pdf-66141848681413. Accessed July 16, 2021.
  • Chopra N, Chowdhury M, Singh AK, et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156–161. doi:10.5582/ddt.2021.01014
  • Hyland ME, Bacon AM, Lanario JW, Davies AF. Symptom frequency and development of a generic functional disorder symptom scale suitable for use in studies of patients with irritable bowel syndrome, fibromyalgia syndrome or chronic fatigue syndrome. Chronic Dis Transl Med. 2019;5(2):129–138. doi:10.1016/j.cdtm.2019.05.003